Paul C. Chin, Ph.D.
Affiliations: | 2004 | University of Texas at Dallas, Richardson, TX, United States |
Area:
Neurodegenerative diseases, HDACsGoogle:
"Paul Chin"Mean distance: 18.08 (cluster 6)
Parents
Sign in to add mentorSantosh D'Mello | grad student | 2004 | UT Dallas | |
(Identification of molecular targets and drugs as potential therapies against neurodegenerative diseases.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Chin PC, Majdzadeh N, D'Mello SR. (2005) Inhibition of GSK3beta is a common event in neuroprotection by different survival factors. Brain Research. Molecular Brain Research. 137: 193-201 |
Johnson K, Liu L, Majdzadeh N, et al. (2005) Inhibition of neuronal apoptosis by the cyclin-dependent kinase inhibitor GW8510: identification of 3' substituted indolones as a scaffold for the development of neuroprotective drugs. Journal of Neurochemistry. 93: 538-48 |
D'Mello SR, Chin PC. (2005) Treating neurodegenerative conditions through the understanding of neuronal apoptosis. Current Drug Targets. Cns and Neurological Disorders. 4: 3-23 |
Chin PC, D'Mello SR. (2005) Brain chemotherapy from the bench to the clinic: targeting neuronal survival with small molecule inhibitors of apoptosis. Frontiers in Bioscience : a Journal and Virtual Library. 10: 552-68 |
Chin PC, D'Mello SR. (2004) Survival of cultured cerebellar granule neurons can be maintained by Akt-dependent and Akt-independent signaling pathways. Brain Research. Molecular Brain Research. 127: 140-5 |
Chin PC, Liu L, Morrison BE, et al. (2004) The c-Raf inhibitor GW5074 provides neuroprotection in vitro and in an animal model of neurodegeneration through a MEK-ERK and Akt-independent mechanism. Journal of Neurochemistry. 90: 595-608 |
Meng F, Liu L, Chin PC, et al. (2002) Akt is a downstream target of NF-kappa B. The Journal of Biological Chemistry. 277: 29674-80 |